Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-23-008064

SrVP/CFO/Prin. Fin&Acctg. Off acquired 269,879 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hamill John P. SrVP/CFO/Prin. Fin&Acctg. Off 2023-01-30 Grant or award +269,879 269,879 D
Derivatives
Hamill John P. SrVP/CFO/Prin. Fin&Acctg. Off 2023-01-30 Grant or award · Employee Stock Option (Right to Buy) +539,758 539,758 D
Loading xslF345X03/tm234680-2_4seq1.xml…